These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32068609)
1. Treatment of Cytomegalovirus Anterior Uveitis at a North American Tertiary Center With Oral Valganciclovir. Bhoopat T; Takhar JS; Oldenburg CE; Keenan JD; Gonzales JA; Margolis TP Cornea; 2020 May; 39(5):584-589. PubMed ID: 32068609 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series. Touhami S; Qu L; Angi M; Bojanova M; Touitou V; Lehoang P; Rozenberg F; Bodaghi B Am J Ophthalmol; 2018 Oct; 194():134-142. PubMed ID: 30055154 [TBL] [Abstract][Full Text] [Related]
3. Treatment of cytomegalovirus anterior uveitis with oral valaciclovir. Sira M; Murray PI Ocul Immunol Inflamm; 2007; 15(1):31-2. PubMed ID: 17365804 [TBL] [Abstract][Full Text] [Related]
4. Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Sobolewska B; Deuter C; Doycheva D; Zierhut M Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):117-24. PubMed ID: 24287937 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. van Boxtel LA; van der Lelij A; van der Meer J; Los LI Ophthalmology; 2007 Jul; 114(7):1358-62. PubMed ID: 17296229 [TBL] [Abstract][Full Text] [Related]
6. Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus. Terada Y; Kaburaki T; Takase H; Goto H; Nakano S; Inoue Y; Maruyama K; Miyata K; Namba K; Sonoda KH; Kaneko Y; Numaga J; Fukushima M; Horiguchi N; Ide M; Ehara F; Miyazaki D; Hasegawa E; Mochizuki M Am J Ophthalmol; 2021 Jul; 227():191-200. PubMed ID: 33773985 [TBL] [Abstract][Full Text] [Related]
7. Clinical Features of CMV-Associated Anterior Uveitis. Chan NS; Chee SP; Caspers L; Bodaghi B Ocul Immunol Inflamm; 2018; 26(1):107-115. PubMed ID: 29172842 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Hwang YS; Lin KK; Lee JS; Chang SH; Chen KJ; Lai CC; Huang JC; Kuo YH; Hsiao CH Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):263-9. PubMed ID: 19784845 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and treatment outcomes of cytomegalovirus anterior uveitis and endotheliitis: A systematic review and meta-analysis. La Distia Nora R; Putera I; Mayasari YD; Hikmahwati W; Pertiwi AM; Ridwan AS; Sitompul R; Westcott M; Chee SP; Pavesio C; Thng ZX; Gupta V; Agrawal R Surv Ophthalmol; 2022; 67(4):1014-1030. PubMed ID: 34954093 [TBL] [Abstract][Full Text] [Related]
14. Tonic Pupil in Cytomegalovirus Anterior Uveitis in an Immunocompetent Adult Male - A Case Report. Babu K; Parameswarappa DC; Sudheer B Ocul Immunol Inflamm; 2018; 26(1):104-106. PubMed ID: 29028408 [TBL] [Abstract][Full Text] [Related]
20. A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol. Takhar JS; Joye AS; Somkijrungroj T; Laovirojjanakul W; Lin CP; Lietman TM; Porco TC; Keenan JD; Gebreegziabher EA; Seitzman GD; Rose-Nussbaumer J; Doan TA; Acharya NR; Gonzales JA BMJ Open; 2019 Dec; 9(12):e033175. PubMed ID: 31862739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]